HAVCR2 and renal cell carcinoma: Additionally, several clinical trials have demonstrated that the expression of Tim-3 is associated with severe dysfunction of T cells in different types of cancers such as non-small-cell lung carcinoma (NSCLC), renal cell carcinoma (RCC), colon cancer and gastric cancer 58, 59.